Epidemiology of COVID-19 Among Indigenous Populations in Brazil

J Racial Ethn Health Disparities. 2022 Jun;9(3):960-966. doi: 10.1007/s40615-021-01035-2. Epub 2021 Apr 12.

Abstract

Background: Due to social and geographical isolation, indigenous people are more vulnerable to adverse conditions; however, there is a lack of data on the epidemics' impact on these populations. Thus, this article's objective was to describe the epidemiological situation of COVID-19 in indigenous communities in Brazil.

Methods: This descriptive observational study was carried out in indigenous communities in the municipality of Amaturá (Amazonas, Brazil). Individuals from the Alto Rio Solimões Special Indigenous Sanitary District (DSEI) who met the Sars-Cov-2 infection case definitions during the period between January and August 2020 were included. For case notification, the definitions adopted by the Ministry of Health of Brazil and by the Special Secretariat for Indigenous Health were considered.

Results: Out of the entire population served by the Alto Rio Solimões DSEI (n = 2890), 109 indigenous people were suspected of having been infected with Sars-Cov-R during the study period; a total of 89 cases were actually confirmed (rate: 3.08 cases/100,000 inhabitants). Most patients diagnosed with COVID-19 were female (56.2%), with a mean age of 32.4 (± 23.6) years. Predominant symptoms were fever (76.4%), dry cough (64%), and headache (60.7%). Complications occurred in 7.9% of the patients; no deaths were reported.

Conclusion: These results enhance the observation that indigenous populations, even if relatively isolated, are exposed to COVID-19. The disease cases assessed showed a favorable evolution, which does not mean reducing the need for caring of this population.

Keywords: Coronavirus infections; Health of ethnic minorities; Health of indigenous people.

Publication types

  • Observational Study

MeSH terms

  • Adult
  • Brazil / epidemiology
  • COVID-19*
  • Cities
  • Female
  • Humans
  • Indigenous Peoples
  • Male
  • SARS-CoV-2